KriyaBio SA logo — Enabling topical ocular administration of biologics

KriyaBio SA

Enabling topical ocular administration of biologics

Founded 2020 Switzerland Geneva, Switzerland 2 employees Non Equity Assistance Biopharma, Biotechnology +2

General Information

Company Name KriyaBio SA
Founded Year 2020
Location Switzerland Geneva, Switzerland
Employees 2
Industries Biopharma, Biotechnology, Pharmaceutical +1
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with KriyaBio SA. To contact KriyaBio SA, visit kriyabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About KriyaBio SA

KriyaBio is a biotech startup founded in 2020, headquartered in Switzerland. The company focuses on enabling topical ocular administration of biologics through its innovative drug delivery solutions built around the proprietary permeation enhancer KB01. This technology has the potential to revolutionize the treatment of age-related macular degeneration (AMD) by replacing current intra-vitreal injections with eye drops. This not only represents a game changer for AMD treatment but also promises significant improvements in patient safety, compliance, and healthcare cost reduction. KriyaBio's last investment was a non-equity assistance investment received on 21st October 2020 from MassChallenge. This investment is a testament to the potential and value of the innovative solutions offered by KriyaBio in the biopharma, biotechnology, and pharmaceutical industries.

Taxonomy: Drug delivery, Permeation enhancement technology, Permeation enhancers, Bioavailability, Ocular drug delivery, Topical drug delivery, Ophthalmic drug formulations, Biologics, AMD treatment, Health care costs, Patient safety, Patient compliance, Needleless delivery, Non-invasive drug delivery, Age-related Macular degeneration

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MassChallenge
21 Oct 2020

KriyaBio SA Alternatives & Competitors

View All Alternatives
KriyaBio SA vs
VIAN Therapeutics
VIAN Therapeutics United States

Protecting sight with a simple eye drop.

Seed
4 employees
Biotechnology, Pharmaceutical
KriyaBio SA vs

Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (S...

Post-IPO Equity
39 employees
Biotechnology, Health Care
KriyaBio SA vs
Oculis
Oculis Switzerland

Visionary Innovation

Post-IPO Equity
77 employees
Biotechnology, Health Care

FAQ About KriyaBio SA

Enabling topical ocular administration of biologics
KriyaBio SA was founded in 2020.
KriyaBio SA is headquartered in Geneva, Switzerland.
KriyaBio SA operates in Biopharma, Biotechnology, Pharmaceutical and Logistics and Delivery. Its work centres on Drug delivery, Permeation enhancement technology, Permeation enhancers and Bioavailability.
KriyaBio SA has approximately 2 employees.
KriyaBio SA has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to KriyaBio SA include VIAN Therapeutics, Clearside Biomedical, Inc., Oculis, Kinarus Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KriyaBio SA and VIAN Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for KriyaBio SA, https://bouncewatch.com/company/kriyabio, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes